Adaptimmune Therapeutics
ADAP
#9324
Rank
S$89.32 M
Marketcap
$0.35
Share price
-20.31%
Change (1 day)
-81.22%
Change (1 year)

P/S ratio for Adaptimmune Therapeutics (ADAP)

P/S ratio as of April 2025 (TTM): 0.3741

According to Adaptimmune Therapeutics's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 5.62. At the end of 2024 the company had a P/S ratio of 0.8480.

P/S ratio history for Adaptimmune Therapeutics from 2016 to 2024

PS ratio at the end of each year

Year P/S ratio Change
20240.8480-71.62%
20232.99-66.09%
20228.81-90.75%
202195.3-54.81%
202021187.41%
20191121013.07%
201810.1-38.91%
201716.5-18.08%
201620.2

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
1.41 278.19%๐Ÿ‡บ๐Ÿ‡ธ USA
0.5232 39.87%๐Ÿ‡บ๐Ÿ‡ธ USA
21.7 5,712.55%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
4.51 1,105.07%๐Ÿ‡บ๐Ÿ‡ธ USA